In humans, urinary NGAL increased not only in AKI, but also in chronic kidney disease (CKD) [37], and is a marker for delayed graft function following kidney transplantation [38], suggesting that the potential of urinary follistatin as a tubular injury marker is not limited to AKI. The gene discussed is LCN2; the disease is chronic kidney disease.